Skip To Main Content
Weikaixin Kong on Muck Rack

Weikaixin Kong

As seen in: Nature, Dove Medical Press
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Weikaixin

Contact Weikaixin, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Integrated network pharmacology, machine learning and experimental val

|
By Weikaixin Kong, Xiangwei Xu, Huiyan Ying
| Dove Medical Press
Back to Journals » OncoTargets and Therapy » Volume 18 Authors Ying H, Kong W, Xu X Received 29 August 2024 Accepted for publication 24 December 2024 Published 16 January 2025 Volume 2025:18 Pages 49—71 DOI https://doi.org/10.2147/OTT.S486300 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Prof.
Open in Who Shared Issue with article?

An immunity and pyroptosis gene-pair signature predicts overall survival in acute myeloid leukemia - Leukemia

|
By Liye He, Caroline Heckman, Tero Aittokallio, Weikaixin Kong
| Nature Verified
Abstract Treatment responses of patients with acute myeloid leukemia (AML) are known to be heterogeneous, posing challenges for risk scoring and treatment stratification. In this retrospective multi-cohort study, we investigated whether combining pyroptosis- and immune-related genes improves prognostic classification of AML patients.
Open in Who Shared Issue with article?
See all 2 articles